Adverse events1,266

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 1,266

Type	Event	Organ system	Group	Affected	At risk
other	Anaemia	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 250 mg Twice Daily	3	11
other	Anaemia	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily	5	15
other	Anaemia	Blood and lymphatic system disorders	Mild Hepatic Impairment: Crizotinib 250 mg Twice Daily	6	20
other	Anaemia	Blood and lymphatic system disorders	Moderate Hepatic Impairment Crizotinib 200 mg Twice Daily	2	10
other	Anaemia	Blood and lymphatic system disorders	Moderate Hepatic Impairment: Crizotinib 250 mg Once Daily	5	16
other	Anaemia	Blood and lymphatic system disorders	Severe Hepatic Impairment Crizotinib 250 mg Once Daily	3	16
other	Coagulopathy	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 250 mg Twice Daily	0	11
other	Coagulopathy	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily	0	15
other	Coagulopathy	Blood and lymphatic system disorders	Mild Hepatic Impairment: Crizotinib 250 mg Twice Daily	0	20
other	Coagulopathy	Blood and lymphatic system disorders	Moderate Hepatic Impairment Crizotinib 200 mg Twice Daily	1	10
other	Coagulopathy	Blood and lymphatic system disorders	Moderate Hepatic Impairment: Crizotinib 250 mg Once Daily	0	16
other	Coagulopathy	Blood and lymphatic system disorders	Severe Hepatic Impairment Crizotinib 250 mg Once Daily	0	16
other	Neutropenia	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 250 mg Twice Daily	0	11
other	Neutropenia	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily	0	15
other	Neutropenia	Blood and lymphatic system disorders	Mild Hepatic Impairment: Crizotinib 250 mg Twice Daily	0	20
other	Neutropenia	Blood and lymphatic system disorders	Moderate Hepatic Impairment Crizotinib 200 mg Twice Daily	0	10
other	Neutropenia	Blood and lymphatic system disorders	Moderate Hepatic Impairment: Crizotinib 250 mg Once Daily	1	16
other	Neutropenia	Blood and lymphatic system disorders	Severe Hepatic Impairment Crizotinib 250 mg Once Daily	1	16
other	Thrombocytopenia	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 250 mg Twice Daily	0	11
other	Thrombocytopenia	Blood and lymphatic system disorders	Normal Hepatic Function: Crizotinib 200/250 mg Twice Daily	0	15

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01576406/events

API reference For AI assistants

Adverse events1,266

Sources 3

Read this list from software.